Universal Diagnostics (UDX) is a Spanish-based biomedicine start-up focused on the development of diagnostics tests for early cancer detection.
UDX started a large-scale research metabolomics project for discovering ex-novo biomarkers for different cancers with high incidence and mortality rate in the world.
UDX has established alliances and collaborations with international universities, companies, biobanks and hospitals to validate the technology in all races and populations.
Following clinical trials and regulatory approval, UDX will offer tests for the early diagnostics of the most prevalent cancers.
UDX’s first product is a blood-based test for the early detection of colorectal cancer and polyps, the precursor to colorectal cancer.